JP Morgan Chase
CRBU icon

JP Morgan Chase’s Caribou Biosciences CRBU Stock Holding History

JP Morgan Chase’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.5K Sell
6,089
-512
-8% -$879 ﹤0.01% 6730
2025
Q4 		$10.5K Buy
+6,601
New +$13.9K ﹤0.01% 6664
2025
Q3 		– Sell
-710
Closed -$895 – 7440
2025
Q2 		$895 Sell
710
-803,844
-100% -$791K ﹤0.01% 6636
2025
Q1 		$735K Sell
804,554
-1,691,368
-68% -$2.2M ﹤0.01% 4550
2024
Q4 		$3.97M Buy
2,495,922
+2,062,563
+476% +$4.15M ﹤0.01% 3571
2024
Q3 		$849K Sell
433,359
-30,668
-7% -$62.8K ﹤0.01% 4573
2024
Q2 		$761K Sell
464,027
-85,026
-15% -$272K ﹤0.01% 4441
2024
Q1 		$2.82M Sell
549,053
-27,931
-5% -$172K ﹤0.01% 3570
2023
Q4 		$3.31M Buy
576,984
+4,606
+0.8% +$22.8K ﹤0.01% 3441
2023
Q3 		$2.74M Sell
572,378
-19,804
-3% -$123K ﹤0.01% 3310
2023
Q2 		$2.52M Sell
592,182
-10,796
-2% -$48.5K ﹤0.01% 3363
2023
Q1 		$3.2M Buy
602,978
+2,881
+0.5% +$17.9K ﹤0.01% 3170
2022
Q4 		$3.77M Sell
600,097
-1,253
-0.2% -$11.1K ﹤0.01% 3059
2022
Q3 		$6.34M Buy
601,350
+91,782
+18% +$855K ﹤0.01% 2518
2022
Q2 		$2.77M Sell
509,568
-6,190
-1% -$47.3K ﹤0.01% 3290
2022
Q1 		$4.74M Buy
515,758
+497,692
+2,755% +$5.24M ﹤0.01% 3055
2021
Q4 		$273K Buy
18,066
+11,002
+156% +$214K ﹤0.01% 5174
2021
Q3 		$169K Buy
+7,064
New +$173K ﹤0.01% 5322

Other funds holding CRBU

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JP Morgan Chase's CRBU Position: Q1 2026 in Review

JP Morgan Chase reduced its Caribou Biosciences (CRBU) stake by 7.8% in Q1 2026, selling an estimated $879 and leaving 6,089 shares worth $10.5K. The position accounts for ﹤0.01% of the portfolio, ranked #6730.

JP Morgan Chase first reported a position in CRBU in Q3 2021 and has held it in 18 quarters since. The position peaked at $6.34M in Q3 2022. 137 funds tracked by Wall St. Rank hold CRBU as of Q1 2026.

  • JP Morgan Chase held 6,089 shares of Caribou Biosciences worth $10.5K as of Q1 2026.
  • JP Morgan Chase sold 512 Caribou Biosciences shares in Q1 2026, an estimated $879.
  • Caribou Biosciences made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #6730 holding.
  • JP Morgan Chase first reported a position in Caribou Biosciences in Q3 2021 and has held it in 18 quarters since.
  • JP Morgan Chase's Caribou Biosciences position peaked at $6.34M in Q3 2022.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.